Top 2009 Hedge Fund Firm Spin-Offs and Fund of Funds Launched with $14.4 billion
|February 3rd, 2010
|HedgeTracker’s Top Hedge Fund Firm Launches of 2009 list profiled the industry’s largest independent hedge fund startups in 2009. Some other newly launched firms, such as those spun-off from other major hedge fund firms and a large fund of fund managers, were excluded from the list. Combined, the four major hedged fund firm launches featured in today's article were launched with $14,400 million in assets under management, which overwhelmingly overshadows the $3,185 million from the Top Hedge Fund Firm Launches list of 2009.|
The largest overall hedge fund firm launch of 2009 was C12 Capital Management, launching with over $13 billion in assets under management. C12 Capital was spun-off from Barclays with a team of 45 bankers to manage Barclays' toxic assets. The firm is run by former Barclays Capital veterans Stephen King and Michael Keeley. C12 Capital manages the Protium Finance LP hedge fund, which has launched with $12.6 billion in assets from Barclays and $450 million from C12 Capital's partners.
The second largest hedge fund launch that did not make the top list is Orchard Capital, which launched with $1.5 billion. Orchard Capital was founded in 2009 by Teall Edds and Stu Wilson in a spin-off from parent company Stark Investments. Stark Investments contributed $1 billion of the firm's initial capital, while new investors provided the rest. Edds and Wilso's new firm utilizes the same strategy they employed while at Stark, investing in Asian debt, equity, and private equity deals.
|Page 1 of 2 Next >>
For Detailed Investor Profiles on these Investors, click below:
| Robert L. Mercer; ||Aaron Rowe ; ||Alex Lin; ||Andrew Law; ||Bob Diamond; ||Brian Stark; ||Bruce Kovner; ||Bruce Kovner; ||Darryl Green; ||Geoffrey Sherry; ||Henrik P. Molin; ||Jim Simons; ||Michael Keeley; ||Mike Roth; ||Robert Frey; ||Stephen King; ||Stu Wilson; ||Teall Edds|| C12 Capital Management LP; ||Barclays Capital Proprietary Trading; ||Barclays Capital*; ||C12 Capital; ||Caxton Alpha Equity LLC; ||Caxton Associates; ||Caxton Associates LLC; ||Caxton Equity Growth (BVI) Ltd; ||Caxton Global Investments USA LLC; ||Caxton Healthcare Trading LLC; ||Caxton High Yield; ||Caxton International LTD; ||Centar Investements (Asia); ||Frey Multi-Strategy Fund; ||Frey Quantitative Strategies (Cayman) Limited; ||Frey Quantitative Strategies LLC; ||Green T G2; ||Lucidus Capital Partners LLP; ||Medallion; ||Nova; ||Orchard Capital Equity; ||Orchard Capital Funds; ||Orchard Capital Singapore; ||Orchard Gemini Fund; ||Protium Finance LP; ||Renaissance Institutional Equities Funds; ||Renaissance Institutional Management LLC; ||Renaissance Technologies LLC; ||Rentec; ||Stark Asia; ||Stark Europe Fund; ||Stark Event Fund; ||Stark Investments; ||Stark Investments Ltd; ||Stark Investments Structured Finance Offshore Fund; ||Staro Asset Management; ||Staro Asset Management*|
More Recent Headlines